 double-blind placebo-control studi therapeut use recombin human erythropoietin anemia chronic renal failur predialysi patient US recombin human erythropoietin predialysi studi group erratum Am kidney di sep seventeen patient anemia chronic renal failur sever mainten dialysi recombin human erythropoietin rhuepo u/kg bodi weight IV time week week anemia correct anemia hematocrit male femal u/kg u/kg u/kg rhuepo placebo group energi level work capac group anemia group uncorrect anemia rhuepo evid therapi deterior renal function serum creatinin reciproc serum creatinin placebo treatment essenti blood pressur hematocrit hypertens patient develop complic hypertens